查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1756457

綜合代謝組 (CMP) 檢測市場（按分析物、按疾病、按最終用途、按國家和地區）－2024 年至 2032 年的行業分析、市場規模、市場佔有率及預測

Comprehensive Metabolic Panel (CMP) Testing Market, By Analytes, By Disease, By End-use, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 378 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

報告重點

2024 年綜合代謝組 (CMP) 測試市場規模價值 126.45 億美元，從 2024 年到 2032 年的複合年成長率為 9.4%。

綜合代謝組（CMP）檢測市場-市場動態

預防性醫療保健需求不斷成長

對預防性醫療保健的日益重視是綜合代謝組 (CMP) 檢測市場的主要驅動力。隨著對早期診斷和疾病管理意識的不斷提高，患者和醫療保健提供者都更加重視常規健康體檢。 CMP 檢測能夠全面了解器官功能和代謝健康狀況，正成為在症狀出現前發現潛在健康問題的重要工具。此外，糖尿病、腎臟病和肝病等慢性疾病的盛行率不斷上升，進一步刺激了需求。政府措施和預防性篩檢的保險覆蓋也促進了市場的擴張。

綜合代謝組（CMP）檢測市場－關鍵見解

根據我們的研究分析師，全球綜合代謝組 (CMP) 測試市場預計在 2024 年至 2032 年期間的複合年成長率約為 9.4%。

2024 年按分析物細分，葡萄糖類別佔據了市場主導地位。

根據疾病，糖尿病部門在 2024 年創造了最多的收入。

按地區分類，2024年北美是收入最高的地區。

綜合代謝組（CMP）測試市場-細分分析：

全球綜合代謝組 (CMP) 測試市場分為四類：分析物、疾病、最終用途和地區。

根據分析物，綜合代謝組 (CMP) 檢測市場細分為鉀 (K+)、鈉 (Na+)、氯 (Cl-)、二氧化碳 (CO2)、葡萄糖、血尿素氮 (BUN)、肌酸酐、鈣 (Ca2+)、白蛋白、總蛋白、鹼性磷酸酶 (ALP)、丙氨酸氨基轉移酶 (ALT)、天冬氨酸轉移酶 (ASTAST) 和總膽固醇。其中，由於全球糖尿病和糖尿病前期病例的增加，血糖檢測佔據了市場主導地位。及早發現異常血糖水平對於管理代謝紊亂和預防併發症至關重要。因此，葡萄糖分析通常包含在常規體檢和疾病特異性篩檢中。對即時檢測和家庭監測的需求不斷成長也有助於提高血糖檢測的頻率和可及性，進一步加強其在 CMP 分析物中的市場領導地位。

依疾病類型分類，綜合代謝組 (CMP) 檢測市場可細分為腎臟病、肝病、糖尿病及其他疾病。其中，糖尿病佔據主導地位，這主要是因為其發生率普遍較高，且全球健康負擔日益加重。 CMP 檢測透過評估血糖水平和評估受疾病影響的器官功能（例如腎臟和肝臟），在糖尿病的診斷和監測中發揮關鍵作用。久坐不動的生活方式、不良的飲食習慣和人口老化導致第 2 型糖尿病發病率不斷上升，這加劇了對常規代謝評估的需求。此外，倡導早期發現和預防保健的宣傳活動和政府醫療保健計畫進一步推動了糖尿病管理中對 CMP 檢測的需求。

綜合代謝組（CMP）檢測市場-地理洞察

從地理分佈來看，綜合代謝組 (CMP) 檢測市場分佈於北美、亞太地區、拉丁美洲、歐洲、中東和非洲。這些地區根據業務來源國進一步分類。

北美憑藉其先進的醫療基礎設施、高昂的醫療支出以及廣泛採用的預防保健措施，在綜合代謝組 (CMP) 檢測市場佔據主導地位。美國尤其如此，其糖尿病、腎臟病和肝病等慢性病的發生率很高。定期健康篩檢和強大的保險覆蓋進一步推動了 CMP 檢測的需求。此外，領先的診斷實驗室的存在以及公眾對早期疾病檢測意識的提高也發揮著至關重要的作用。醫療機構的策略性舉措和政府的優惠政策鞏固了北美在全球 CMP 檢測市場的領導地位。

受慢性病發病率上升和醫療保健意識增強的推動，亞太地區正成為中醫（CMP）檢測市場的關鍵成長區域。由於快速城鎮化、生活方式的轉變以及中產階級人口的不斷壯大，中國、印度和日本等國家對診斷檢測的需求激增。該地區各國政府正在投資醫療基礎設施並推廣預防性保健計劃，從而支持了市場的成長。此外，隨著公立和私立醫療體系的擴張，診斷服務的可負擔性和可近性也不斷提高。這些因素共同使亞太地區成為中醫檢測最具潛力的市場之一。

綜合代謝組（CMP）測試市場-競爭格局：

CMP 檢測市場由雅培、Quest Diagnostics、美國實驗室控股公司 (LabCorp) 和 Sonic Healthcare 等知名診斷公司主導。這些公司提供種類繁多、準確度高、可靠性高的代謝和生化檢測產品。對研發和先進診斷技術的大力投入有助於維持合規性和產品創新。新進業者專注於整合人工智慧和即時檢測，以提高診斷速度和可近性。這種競爭環境推動了檢測效率、準確性和便利性的不斷提升，支持 CMP 檢測在全球臨床和預防性醫療保健領域的更廣泛應用。

最新動態：

2024 年 3 月，雅培推出了下一代即時血液分析儀，旨在進行快速代謝組檢測，縮短遠距醫療環境中的周轉時間和提高可及性。

2025 年 1 月，Quest Diagnostics 在德州開設了一家最先進的檢測設施，擴大了其實驗室服務，提高了代謝和基因檢測的能力，以滿足不斷成長的需求。

目錄

第1章：綜合代謝組（CMP）檢測市場概述

  • 研究範圍
  • 市場估計年限

第2章：執行摘要

  • 市場片段
    • 綜合代謝組 (CMP) 檢測市場片段（分析者）
    • 綜合代謝組 (CMP) 檢測市場（按疾病）
    • 綜合代謝組 (CMP) 檢測市場片段（依最終用途）
    • 綜合代謝組 (CMP) 檢測市場（按國家/地區）
    • 綜合代謝組 (CMP) 檢測市場（按地區）
  • 競爭洞察

第3章：綜合代謝組 (CMP) 檢測關鍵市場趨勢

  • 綜合代謝組（CMP）檢測市場促進因素
    • 市場促進因素的影響分析
  • 綜合代謝組（CMP）檢測市場限制
    • 市場限制的影響分析
  • 綜合代謝組（CMP）檢測市場機會
  • 綜合代謝組（CMP）檢測市場未來趨勢

第4章：綜合代謝組（CMP）檢測產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第5章：綜合代謝組 (CMP) 檢測市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • 新冠疫情後影響分析
    • 表現最佳的市場區隔
    • 邊際成長細分市場
    • 最鬆散的細分市場
    • 邊際損失市場區隔

第6章：綜合代謝組 (CMP) 檢測市場格局

  • 2023年綜合代謝組（CMP）檢測市佔率分析
  • 按主要製造商分類的細分數據
    • 成熟玩家分析
    • 新興企業分析

第7章：綜合代謝組 (CMP) 檢測市場 - 按分析者

  • 概述
    • 細分市場佔有率分析（按分析者）
    • 鉀+
    • 鈉離子
    • 氯離子
    • 二氧化碳
    • 葡萄糖
    • 包子
    • 肌酸酐
    • 鈣離子
    • 白蛋白
    • 總蛋白
    • 鹼性磷酸酶
    • 丙胺酸
    • AST
    • 總膽紅素

第 8 章：綜合代謝組 (CMP) 檢測市場 - 按疾病

  • 概述
    • 按疾病細分的佔有率分析
    • 腎臟疾病
    • 肝臟疾病
    • 糖尿病
    • 其他

第9章：綜合代謝組 (CMP) 檢測市場 - 按最終用途

  • 概述
    • 按最終用途分類的細分市場佔有率分析
    • 實驗室
      • 急診室
      • 醫院病房
      • 初級保健
      • 藥局
      • 遠距醫療
    • 概念驗證
      • 急診室
      • 醫院病房
      • 初級保健
      • 藥局
      • 遠距醫療
    • PoC（工具）
      • Piccolo Xpress
      • Skyla-HB1
      • DRI-CHEM NX500
      • 其他

第 10 章：綜合代謝組 (CMP) 檢測市場 - 按地理分類

  • 介紹
    • 按地區分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美綜合代謝組 (CMP) 檢測主要製造商
    • 北美市場規模及預測（按國家/地區）
    • 北美市場規模與預測（分析師）
    • 北美市場規模及預測（按疾病）
    • 北美市場規模和預測，按最終用途
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲綜合代謝組 (CMP) 檢測主要製造商
    • 歐洲市場規模及預測（按國家/地區）
    • 歐洲市場規模及預測（分析師）
    • 歐洲市場規模及預測（按疾病）
    • 歐洲市場規模和預測，按最終用途
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 英國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區綜合代謝組 (CMP) 檢測主要製造商
    • 亞太市場規模及預測（按國家/地區）
    • 亞太市場規模及預測（分析師）
    • 亞太市場規模及預測（按疾病）
    • 亞太市場規模及預測（依最終用途）
    • 印度
    • 中國
    • 韓國
    • 日本
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲綜合代謝組 (CMP) 檢測主要製造商
    • 拉丁美洲市場規模及預測（按國家/地區）
    • 拉丁美洲市場規模及預測（分析師）
    • 拉丁美洲市場規模及預測（按疾病）
    • 拉丁美洲市場規模和預測（按最終用途）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲綜合代謝組 (CMP) 檢測主要製造商
    • 中東和非洲市場規模及預測（按國家/地區）
    • 分析師對中東和非洲市場規模和預測
    • 中東和非洲市場規模及預測（按疾病）
    • 中東和非洲市場規模和預測（按最終用途）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 其餘地區

第 11 章：主要供應商分析-綜合代謝組 (CMP) 測試產業

  • 競爭儀錶板
  • 公司簡介
    • Abbott
    • Quest Diagnostics
    • Laboratory Corporation of America Holdings Limited
    • Sonic Healthcare
    • Unipath
    • SYNLAB International GmbH
    • ARUP Laboratories
    • Genoptix Inc.
    • Nova Medical
    • Others

第 12 章：360 度分析師視角

第 13 章：附錄

  • 研究方法
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
簡介目錄
Product Code: ANV5325

REPORT HIGHLIGHT

Comprehensive Metabolic Panel (CMP) Testing Market size was valued at USD 12,645 Million in 2024, expanding at a CAGR of 9.4% from 2024 to 2032.

A Comprehensive Metabolic Panel (CMP) is a blood test that measures 14 different substances in the blood to provide information about the body's chemical balance and metabolism. It helps evaluate organ function, especially the liver and kidneys, and monitors conditions such as diabetes, liver disease, and electrolyte imbalances. The CMP includes tests for glucose, calcium, electrolytes (sodium, potassium, carbon dioxide, chloride), kidney function markers (BUN, creatinine), and liver enzymes (ALP, ALT, AST, bilirubin, albumin, total protein). Often part of routine health checkups, it aids in early detection and ongoing monitoring of various health conditions to support timely medical intervention.

Comprehensive Metabolic Panel (CMP) Testing Market- Market Dynamics

Growing Demand for Preventive Healthcare

The rising emphasis on preventive healthcare is a major driver of the Comprehensive Metabolic Panel (CMP) testing market. With increasing awareness about early diagnosis and disease management, both patients and healthcare providers are prioritizing routine health checkups. CMP tests, which offer a broad overview of organ function and metabolic health, are becoming essential tools for identifying potential health issues before symptoms appear. Additionally, the growing prevalence of chronic conditions such as diabetes, kidney disease, and liver disorders is further fueling demand. Government initiatives and insurance coverage for preventive screenings are also contributing to the market's expansion.

Comprehensive Metabolic Panel (CMP) Testing Market- Key Insights

According to our research analyst, the global Comprehensive Metabolic Panel (CMP) Testing Market is expected to develop at a CAGR of approximately 9.4% between 2024-2032.

Segmented by Analytes in 2024, the Glucose category dominated the market.

Based on Disease, the Diabetes segment generated the most income in 2024.

On the basis of region, in 2024, North America was the region with the highest revenue.

Comprehensive Metabolic Panel (CMP) Testing Market- Segmentation Analysis:

The global Comprehensive Metabolic Panel (CMP) Testing Market is divided into Four categories: Analytes, Disease, End-use, and Region.

By analytes, the Comprehensive Metabolic Panel (CMP) testing market is segmented into potassium (K+), sodium (Na+), chloride (Cl-), carbon dioxide (CO2), glucose, blood urea nitrogen (BUN), creatinine, calcium (Ca2+), albumin, total protein, alkaline phosphatase (ALP), alanine aminotransferase (ALT), aspartate aminotransferase (AST), and total bilirubin. Among these, glucose testing dominates the market due to the global rise in diabetes and prediabetes cases. Early detection of abnormal blood sugar levels is critical in managing metabolic disorders and preventing complications. As a result, glucose analysis is commonly included in both routine checkups and disease-specific screenings. The increasing demand for point-of-care testing and home-based monitoring also contributes to the higher frequency and accessibility of glucose testing, further strengthening its market leadership within CMP analytes.

By disease, the Comprehensive Metabolic Panel (CMP) testing market is segmented into kidney diseases, liver diseases, diabetes, and others. Among these, diabetes is the dominant segment, primarily due to its widespread prevalence and the growing global health burden associated with the condition. CMP tests play a critical role in diagnosing and monitoring diabetes by evaluating blood glucose levels and assessing organ functions affected by the disease, such as the kidneys and liver. The increasing incidence of type 2 diabetes, driven by sedentary lifestyles, poor dietary habits, and aging populations, has heightened the need for routine metabolic assessments. Moreover, awareness campaigns and government healthcare programs promoting early detection and preventive care have further propelled the demand for CMP testing in diabetes management.

Comprehensive Metabolic Panel (CMP) Testing Market- Geographical Insights

Geographically, the Comprehensive Metabolic Panel (CMP) Testing Market is distributed throughout North America, Asia Pacific, Latin America, Europe, the Middle East, and Africa. These regions are further divided based on the nations bringing in business.

North America dominates the Comprehensive Metabolic Panel (CMP) testing market due to its advanced healthcare infrastructure, high healthcare spending, and widespread adoption of preventive care practices. The United States, in particular, contributes significantly with a high prevalence of chronic conditions such as diabetes, kidney disorders, and liver diseases. Regular health screening and strong insurance coverage further drive the demand for CMP tests. Additionally, the presence of leading diagnostic laboratories and increased public awareness about early disease detection play crucial roles. Strategic initiatives by healthcare providers and favorable government policies reinforce North America's leadership in the global CMP testing market.

Asia Pacific is emerging as a key growth region in the CMP testing market, driven by the rising incidence of chronic diseases and increasing healthcare awareness. Countries like China, India, and Japan are experiencing a surge in demand for diagnostic testing due to rapid urbanization, changing lifestyles, and expanding middle-class populations. Governments in the region are investing in healthcare infrastructure and promoting preventive health programs, which support market growth. Furthermore, the affordability and accessibility of diagnostic services are improving through both public and private healthcare expansions. These factors collectively position Asia Pacific as one of the most promising markets for CMP testing.

Comprehensive Metabolic Panel (CMP) Testing Market- Competitive Landscape:

The CMP testing market is dominated by established diagnostic firms such as Abbott, Quest Diagnostics, Laboratory Corporation of America Holdings (LabCorp), and Sonic Healthcare. These companies offer a broad range of metabolic and biochemical tests with high accuracy and reliability. Heavy investments in R&D and advanced diagnostic technologies help maintain regulatory compliance and product innovation. New entrants focus on integrating AI and point-of-care testing to enhance diagnostic speed and accessibility. This competitive environment drives continuous advancements in testing efficiency, accuracy, and convenience, supporting wider adoption of CMP testing in clinical and preventive healthcare settings globally.

Recent Developments:

In March 2024, Abbott launched a next-generation point-of-care blood analyzer designed for rapid metabolic panel testing, improving turnaround time and accessibility in remote healthcare settings.

In January 2025, Quest Diagnostics expanded its laboratory services by opening a state-of-the-art testing facility in Texas, boosting capacity for metabolic and genetic testing to meet rising demand.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL COMPREHENSIVE METABOLIC PANEL (CMP) TESTING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Abbott
  • Quest Diagnostics
  • Laboratory Corporation of America Holdings Limited
  • Sonic Healthcare
  • Unipath
  • SYNLAB International GmbH
  • ARUP Laboratories
  • Genoptix Inc.
  • Nova Medical
  • Others

GLOBAL COMPREHENSIVE METABOLIC PANEL (CMP) TESTING MARKET, BY ANALYTES - MARKET ANALYSIS, 2019 - 2032

  • K+
  • Na+
  • Cl-
  • CO2
  • Glucose
  • BUN
  • Creatinine
  • Ca++
  • Albumin
  • Total Protein
  • ALP
  • ALT
  • AST
  • Total Bilirubin

GLOBAL COMPREHENSIVE METABOLIC PANEL (CMP) TESTING MARKET, BY DISEASE - MARKET ANALYSIS, 2019 - 2032

  • Kidney Diseases
  • Liver Diseases
  • Diabetes
  • Others

GLOBAL COMPREHENSIVE METABOLIC PANEL (CMP) TESTING MARKET, BY END-USE - MARKET ANALYSIS, 2019 - 2032

  • Laboratories
  • Emergency Departments
  • Hospital Wards
  • Primary Care
  • Pharmacy
  • Telemedicine
  • PoC
  • Emergency Departments
  • Hospital Wards
  • Primary Care
  • Pharmacy
  • Telemedicine
  • PoC (Instruments)
  • Piccolo Xpress
  • Skyla-HB1
  • DRI-CHEM NX500
  • Others

GLOBAL COMPREHENSIVE METABOLIC PANEL (CMP) TESTING MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Comprehensive Metabolic Panel (CMP) Testing Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Comprehensive Metabolic Panel (CMP) Testing Market Snippet by Analytes
    • 2.1.2. Comprehensive Metabolic Panel (CMP) Testing Market Snippet by Disease
    • 2.1.3. Comprehensive Metabolic Panel (CMP) Testing Market Snippet by End Use
    • 2.1.4. Comprehensive Metabolic Panel (CMP) Testing Market Snippet by Country
    • 2.1.5. Comprehensive Metabolic Panel (CMP) Testing Market Snippet by Region
  • 2.2. Competitive Insights

3. Comprehensive Metabolic Panel (CMP) Testing Key Market Trends

  • 3.1. Comprehensive Metabolic Panel (CMP) Testing Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Comprehensive Metabolic Panel (CMP) Testing Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Comprehensive Metabolic Panel (CMP) Testing Market Opportunities
  • 3.4. Comprehensive Metabolic Panel (CMP) Testing Market Future Trends

4. Comprehensive Metabolic Panel (CMP) Testing Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Comprehensive Metabolic Panel (CMP) Testing Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Comprehensive Metabolic Panel (CMP) Testing Market Landscape

  • 6.1. Comprehensive Metabolic Panel (CMP) Testing Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Comprehensive Metabolic Panel (CMP) Testing Market - By Analytes

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Analytes, 2023 & 2032 (%)
    • 7.1.2. K+
    • 7.1.3. Na+
    • 7.1.4. Cl-
    • 7.1.5. CO2
    • 7.1.6. Glucose
    • 7.1.7. BUN
    • 7.1.8. Creatinine
    • 7.1.9. Ca++
    • 7.1.10. Albumin
    • 7.1.11. Total Protein
    • 7.1.12. ALP
    • 7.1.13. ALT
    • 7.1.14. AST
    • 7.1.15. Total Bilirubin

8. Comprehensive Metabolic Panel (CMP) Testing Market - By Disease

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Disease, 2023 & 2032 (%)
    • 8.1.2. Kidney Diseases
    • 8.1.3. Liver Diseases
    • 8.1.4. Diabetes
    • 8.1.5. Others

9. Comprehensive Metabolic Panel (CMP) Testing Market - By End Use

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End Use, 2023 & 2032 (%)
    • 9.1.2. Laboratories
      • 9.1.2.1. Emergency Departments
      • 9.1.2.2. Hospital Wards
      • 9.1.2.3. Primary Care
      • 9.1.2.4. Pharmacy
      • 9.1.2.5. Telemedicine
    • 9.1.3. PoC
      • 9.1.3.1. Emergency Departments
      • 9.1.3.2. Hospital Wards
      • 9.1.3.3. Primary Care
      • 9.1.3.4. Pharmacy
      • 9.1.3.5. Telemedicine
    • 9.1.4. PoC (Instruments)
      • 9.1.4.1. Piccolo Xpress
      • 9.1.4.2. Skyla-HB1
      • 9.1.4.3. DRI-CHEM NX500
      • 9.1.4.4. Others

10. Comprehensive Metabolic Panel (CMP) Testing Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Comprehensive Metabolic Panel (CMP) Testing Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Comprehensive Metabolic Panel (CMP) Testing Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.3.8. France
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. France Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
      • 10.3.8.4. France Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.3.8.5. France Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.3.9. Italy
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. Italy Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
      • 10.3.9.4. Italy Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.3.9.5. Italy Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.3.10. Spain
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. United Kingdom Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
      • 10.3.10.4. United Kingdom Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.3.10.5. United Kingdom Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.3.11. United Kingdom
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.3. United Kingdom Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
      • 10.3.11.4. United Kingdom Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.3.11.5. United Kingdom Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.3.12. Russia
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Russia Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Russia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Russia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.3.13. Netherlands
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Netherlands Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Netherlands Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Netherlands Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.3.14. Sweden
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Sweden Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Sweden Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Sweden Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.3.15. Poland
      • 10.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.2. Poland Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
      • 10.3.15.3. Poland Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Poland Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.3.16. Rest of Europe
      • 10.3.16.1. Overview
      • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.16.3. Rest of the Europe Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
      • 10.3.16.4. Rest of the Europe Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.3.16.5. Rest of the Europe Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Comprehensive Metabolic Panel (CMP) Testing Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.4.9. South Korea
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. South Korea Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
      • 10.4.9.4. South Korea Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.4.9.5. South Korea Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.4.10. Japan
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. Japan Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
      • 10.4.10.4. Japan Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.4.10.5. Japan Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Comprehensive Metabolic Panel (CMP) Testing Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Comprehensive Metabolic Panel (CMP) Testing Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Analytes, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Comprehensive Metabolic Panel (CMP) Testing Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Abbott
    • 11.2.2. Quest Diagnostics
    • 11.2.3. Laboratory Corporation of America Holdings Limited
    • 11.2.4. Sonic Healthcare
    • 11.2.5. Unipath
    • 11.2.6. SYNLAB International GmbH
    • 11.2.7. ARUP Laboratories
    • 11.2.8. Genoptix Inc.
    • 11.2.9. Nova Medical
    • 11.2.10. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us